Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies

Journal of Virology

Volumn 84, Issue 23, 2010, Pages 12210-12225

  Pennella, Mario A ^a   Liu, Yue ^b   Woo, Jennifer L ^c   Kim, Chongwoo A ^d   Berk, Arnold J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KECK GRADUATE INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

E1B PROTEIN; MUTANT PROTEIN; PROTEIN P53; SUMO 1 PROTEIN; VIRUS PROTEIN;

ADENOVIRUS 5; AGGRESOME; ARTICLE; CELL NUCLEUS INCLUSION BODY; COMPLEX FORMATION; GENE MUTATION; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR EXPORT; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; SUMOYLATION; VIRUS INFECTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOVIRUS E1B PROTEINS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DIMERIZATION; HUMANS; INTRANUCLEAR INCLUSION BODIES; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; MUTATION; NUCLEAR PROTEINS; PHOTOBLEACHING; SUMO-1 PROTEIN; SUMOYLATION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

ADENOVIRIDAE;

EID: 78049525016     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01442-10     Document Type: Article

References (86)

1. Araujo, F. D., T. H. Stracker, C. T. Carson, D. V. Lee, and M. D. Weitzman. 2005. Adenovirus type 5 E4orf3 protein targets the Mre11 complex to cytoplasmic aggresomes. J. Virol. 79:11382-11391.
2. Baker, A., K. J. Rohleder, L. A. Hanakahi, and G. Ketner. 2007. Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation. J. Virol. 81:7034-7040. (Pubitemid 46986639)
3. Berk, A. J. 2007. Adenoviridae: the viruses and their replication, fifth ed. Lippincott Williams & Wilkins, Philadelphia, PA.
4. Berk, A. J. 2005. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24:7673-7685. (Pubitemid 41670670)
5. Bernardi, R., and P. P. Pandolfi. 2007. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 8:1006-1016.
6. Bischof, O., O. Kirsh, M. Pearson, K. Itahana, P. G. Pelicci, and A. Dejean. 2002. Deconstructing PML-induced premature senescence. EMBO J. 21: 3358-3369.
7. Blackford, A. N., and R. J. Grand. 2009. Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation. J. Virol. 83:4000-4012.
8. Blair Zajdel, M. E., and G. E. Blair. 1988. The intracellular distribution of the transformation-associated protein p53 in adenovirus-transformed rodent cells. Oncogene 2:579-584.
9. Boggio, R., R. Colombo, R. T. Hay, G. F. Draetta, and S. Chiocca. 2004. A mechanism for inhibiting the SUMO pathway. Mol. Cell 16:549-561.
10. Bridge, E., and G. Ketner. 1989. Redundant control of adenovirus late gene expression by early region 4. J. Virol. 63:631-638. (Pubitemid 19057228)
11. Brosh, R., and V. Rotter. 2010. Transcriptional control of the proliferation cluster by the tumor suppressor p53. Mol. Biosyst. 6:17-29.
12. Cardoso, F. M., S. E. Kato, W. Huang, S. J. Flint, and R. A. Gonzalez. 2008. An early function of the adenoviral E1B 55 kDa protein is required for the nuclear relocalization of the cellular p53 protein in adenovirus-infected normal human cells. Virology 378:339-346.
13. Carson, C. T., R. A. Schwartz, T. H. Stracker, C. E. Lilley, D. V. Lee, and M. D. Weitzman. 2003. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J. 22:6610-6620.
14. Coutts, A. S., and N. B. La Thangue. 2005. The p53 response: emerging levels of co-factor complexity. Biochem. Biophys. Res. Commun. 331:778-785.
15. Crook, T., R. L. Ludwig, N. J. Marston, D. Willkomm, K. H. Vousden. 1996. Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6. Virology 217:285-292.
16. Dallaire, F., P. Blanchette, P. Groitl, T. Dobner, and P. E. Branton. 2009. Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6/ E1B 55-kilodalton E3 ubiquitin ligase complex. J. Virol. 83:5329-5338.
17. Davison, T. S., P. Yin, E. Nie, C. Kay, and C. H. Arrowsmith. 1998. Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome. Oncogene 17: 651-656.
18. Debbas, M., and E. White. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:546-554. (Pubitemid 23125256)
19. Dobbelstein, M., J. Roth, W. T. Kimberly, A. J. Levine, and T. Shenk. 1997. Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence. EMBO J. 16:4276-4284.
20. Doucas, V., A. M. Ishov, A. Romo, H. Juguilon, M. D. Weitzman, R. M. Evans, and G. G. Maul. 1996. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 10:196-207.
21. Dundr, M., and T. Misteli. 2003. Measuring dynamics of nuclear proteins by photobleaching. Curr. Protoc. Cell Biol. Chapter 13:Unit 13.5.
22. Endter, C., B. Hartl, T. Spruss, J. Hauber, and T. Dobner. 2005. Blockage of CRM1-dependent nuclear export of the adenovirus type 5 early region 1B 55-kDa protein augments oncogenic transformation of primary rat cells. Oncogene 24:55-64. (Pubitemid 40143865)
23. Endter, C., J. Kzhyshkowska, R. Stauber, and T. Dobner. 2001. SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc. Natl. Acad. Sci. U. S. A. 98:11312-11317.
24. Everett, R. D., and M. K. Chelbi-Alix. 2007. PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89:819-830.
25. Fogal, V., M. Gostissa, P. Sandy, P. Zacchi, T. Sternsdorf, K. Jensen, P. P. Pandolfi, H. Will, C. Schneider, and G. Del Sal. 2000. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19:6185-6195.
26. Fuster, J. J., S. M. Sanz-Gonzalez, U. M. Moll, and V. Andres. 2007. Classic and novel roles of p53: prospects for anticancer therapy. Trends Mol. Med. 13:192-199.
27. García-Mata, R., Z. Bebok, E. J. Sorscher, and E. S. Sztul. 1999. Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J. Cell Biol. 146:1239-1254.
28. Garcia-Mata, R., Y. S. Gao, and E. Sztul. 2002. Hassles with taking out the garbage: aggravating aggresomes. Traffic 3:388-396. (Pubitemid 34746406)
29. Goodrum, F. D., T. Shenk, and D. A. Ornelles. 1996. Adenovirus early region 4 34-kilodalton protein directs the nuclear localization of the early region 1B 55-kilodalton protein in primate cells. J. Virol. 70:6323-6335.
30. Gorski, S. A., M. Dundr, and T. Misteli. 2006. The road much traveled: trafficking in the cell nucleus. Curr. Opin. Cell Biol. 18:284-290.
31. Gostissa, M., A. Hengstermann, V. Fogal, P. Sandy, S. E. Schwarz, M. Scheffner, and G. Del Sal. 1999. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18:6462-6471.
32. Green, D. R., and G. Kroemer. 2009. Cytoplasmic functions of the tumour suppressor p53. Nature 458:1127-1130.
33. Handwerger, K. E., and J. G. Gall. 2006. Subnuclear organelles: new insights into form and function. Trends Cell Biol. 16:19-26.
34. Harada, J. N., A. Shevchenko, D. C. Pallas, and A. J. Berk. 2002. Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J. Virol. 76:9194-9206.
35. Hay, R. T. 2005. SUMO: a history of modification. Mol. Cell 18:1-12.
36. Heun, P. 2007. SUMOrganization of the nucleus. Curr. Opin. Cell Biol. 19:350-355.
37. Hopfner, K. P. 2009. DNA double-strand breaks come into focus. Cell 139:25-27.
38. Huang, M. M., and P. Hearing. 1989. Adenovirus early region 4 encodes two gene products with redundant effects in lytic infection. J. Virol. 63:2605-2615.
39. Jensen, K., C. Shiels, and P. S. Freemont. 2001. PML protein isoforms and the RBCC/TRIM motif. Oncogene 20:7223-7233.
40. Joerger, A. C., and A. R. Fersht. 2008. Structural biology of the tumor suppressor p53. Annu. Rev. Biochem. 77:557-582.
41. Kao, C. C., P. R. Yew, and A. J. Berk. 1990. Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins. Virology 179:806-814.
42. Karen, K. A., P. J. Hoey, C. S. Young, and P. Hearing. 2009. Temporal regulation of the Mre11-Rad50-Nbs1 complex during adenovirus infection. J. Virol. 83:4565-4573.
43. Kerscher, O. 2007. SUMO junction - what's your function? New insights through SUMO-interacting motifs. EMBO Rep. 8:550-555. (Pubitemid 47214708)
44. Kindsmüller, K., P. Groitl, B. Hartl, P. Blanchette, J. Hauber, and T. Dobner. 2007. Intranuclear targeting and nuclear export of the adenovirus E1B-55K protein are regulated by SUMO1 conjugation. Proc. Natl. Acad. Sci. U. S. A. 104:6684-6689.
45. Kopito, R. R. 2000. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10:524-530.
46. Krätzer, F., O. Rosorius, P. Heger, N. Hirschmann, T. Dobner, J. Hauber, and R. H. Stauber. 2000. The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2. Oncogene 19:850-857.
47. Krieghoff-Henning, E., and T. G. Hofmann. 2008. Role of nuclear bodies in apoptosis signalling. Biochim. Biophys. Acta 1783:2185-2194.
48. Lee, J. H., and T. T. Paull. 2007. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 26:7741-7748.
49. Leppard, K. N., and R. D. Everett. 1999. The adenovirus type 5 E1b 55K and E4 Orf3 proteins associate in infected cells and affect ND10 components. J. Gen. Virol. 80(Pt. 4):997-1008.
50. Lethbridge, K. J., G. E. Scott, and K. N. Leppard. 2003. Nuclear matrix localization and SUMO-1 modification of adenovirus type 5 E1b 55K protein are controlled by E4 Orf6 protein. J. Gen. Virol. 84:259-268.
51. Lin, J., J. Chen, B. Elenbaas, and A. J. Levine. 1994. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8:1235-1246.
52. Liu, B., and K. Shuai. 2008. Regulation of the sumoylation system in gene expression. Curr. Opin. Cell Biol. 20:288-293.
53. Liu, Y., A. Shevchenko, A. Shevchenko, and A. J. Berk. 2005. Adenovirus exploits the cellular aggresome response to accelerate inactivation of the MRN complex. J. Virol. 79:14004-14016.
54. Lowe, S. W., and H. E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7:535-545.
55. Martin, M. E., and A. J. Berk. 1998. Adenovirus E1B 55K represses p53 activation in vitro. J. Virol. 72:3146-3154.
56. Martin, M. E., and A. J. Berk. 1999. Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription. Mol. Cell. Biol. 19:3403-3414.
57. Morawska-Onyszczuk, M., K. Bienkowska-Szewczyk, and M. Dobbelstein. 2010. Self-association of adenovirus type 5 E1B-55 kDa as well as p53 is essential for their mutual interaction. Oncogene 29:1773-1786.
58. Muller, S., and T. Dobner. 2008. The adenovirus E1B-55K oncoprotein induces SUMO modification of p53. Cell Cycle 7:754-758. (Pubitemid 351520039)
59. Müller, S., M. J. Matunis, and A. Dejean. 1998. Conjugation with the ubiquitin- related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17:61-70. (Pubitemid 28041048)
60. Nie, L., M. Sasaki, and C. G. Maki. 2007. Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination. J. Biol. Chem. 282:14616-14625.
61. Ornelles, D. A., and T. Shenk. 1991. Localization of the adenovirus early region 1B 55-kilodalton protein during lytic infection: association with nuclear viral inclusions requires the early region 4 34-kilodalton protein. J. Virol. 65:424-429.
62. Ouyang, J., A. Valin, and G. Gill. 2009. Regulation of transcription factor activity by SUMO modification. Methods Mol. Biol. 497:141-152.
63. Phair, R. D., S. A. Gorski, and T. Misteli. 2004. Measurement of dynamic protein binding to chromatin in vivo, using photobleaching microscopy. Methods Enzymol. 375:393-414.
64. Querido, E., P. Blanchette, Q. Yan, T. Kamura, M. Morrison, D. Boivin, W. G. Kaelin, R. C. Conaway, J. W. Conaway, and P. E. Branton. 2001. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a cullin-containing complex. Genes Dev. 15: 3104-3117.
65. Querido, E., R. C. Marcellus, A. Lai, R. Charbonneau, J. G. Teodoro, G. Ketner, and P. E. Branton. 1997. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J. Virol. 71: 3788-3798.
66. Rodriguez, M. S., J. M. Desterro, S. Lain, C. A. Midgley, D. P. Lane, and R. T. Hay. 1999. SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18:6455-6461.
67. Rytinki, M. M., S. Kaikkonen, P. Pehkonen, T. Jaaskelainen, and J. J. Palvimo. 2009. PIAS proteins: pleiotropic interactors associated with SUMO. Cell. Mol. Life Sci. 66:3029-3041.
68. Sarnow, P., C. A. Sullivan, and A. J. Levine. 1982. A monoclonal antibody detecting the adenovirus type 5-E1b-58Kd tumor antigen: characterization of the E1b-58Kd tumor antigen in adenovirus-infected and -transformed cells. Virology 120:510-517.
69. Shaw, G., S. Morse, M. Ararat, and F. L. Graham. 2002. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16:869-871.
70. Shen, T. H., H. K. Lin, P. P. Scaglioni, T. M. Yung, and P. P. Pandolfi. 2006. The mechanisms of PML-nuclear body formation. Mol. Cell 24:331-339.
71. Shepard, R. N., and D. A. Ornelles. 2004. Diverse roles for E4orf3 at late times of infection revealed in an E1B 55-kilodalton protein mutant background. J. Virol. 78:9924-9935.
72. Sprague, B. L., and J. G. McNally. 2005. FRAP analysis of binding: proper and fitting. Trends Cell Biol. 15:84-91.
73. Spurgeon, M. E., and D. A. Ornelles. 2009. The adenovirus E1B 55-kilodalton and E4 open reading frame 6 proteins limit phosphorylation of eIF2alpha during the late phase of infection. J. Virol. 83:9970-9982.
74. Steegenga, W. T., N. Riteco, A. G. Jochemsen, F. J. Fallaux, and J. L. Bos. 1998. The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells. Oncogene 16:349-357.
75. Stracker, T. H., C. T. Carson, and M. D. Weitzman. 2002. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418:348-352.
76. Van Damme, E., K. Laukens, T. H. Dang, and X. Van Ostade. 2010. A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics. Int. J. Biol. Sci. 6:51-67.
77. Vousden, K. H., and C. Prives. 2009. Blinded by the light: the growing complexity of p53. Cell 137:413-431.
78. Weiden, M. D., and H. S. Ginsberg. 1994. Deletion of the E4 region of the genome produces adenovirus DNA concatemers. Proc. Natl. Acad. Sci. U. S. A. 91:153-157.
79. Weitzman, M. D., and D. A. Ornelles. 2005. Inactivating intracellular antiviral responses during adenovirus infection. Oncogene 24:7686-7696.
80. Wienzek, S., J. Roth, and M. Dobbelstein. 2000. E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53. J. Virol. 74:193-202. (Pubitemid 30002898)
81. Woo, J., and A. J. Berk. 2007. Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export. J. Virol. 81:575-587.
82. Wu, S. Y., and C. M. Chiang. 2009. Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding. EMBO J. 28:1246-1259.
83. Yew, P. R., and A. J. Berk. 1992. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 357:82-85.
84. Zantema, A., J. A. Fransen, A. Davis-Olivier, F. C. Ramaekers, G. P. Vooijs, B. DeLeys, and A. J. Van der Eb. 1985. Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies. Virology 142:44-58.
85. Zhang, X. D., J. Goeres, H. Zhang, T. J. Yen, A. C. Porter, and M. J. Matunis. 2008. SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis. Mol. Cell 29:729-741.
86. Zhong, S., S. Muller, S. Ronchetti, P. S. Freemont, A. Dejean, and P. P. Pandolfi. 2000. Role of SUMO-1-modified PML in nuclear body formation. Blood 95:2748-2752.